Skip to main content
. 2017 Nov 6;3:17076. doi: 10.1038/cddiscovery.2017.76

Figure 5.

Figure 5

Ablating GRP75 preserves mitochondrial morphology and attenuates mitochondrial ROS formation in response to glutamate treatment. (a) Representative images of mitochondrial morphology in HT22 CTR and cells transfected with scrambled siRNA (Scr) or siRNA against GRP75 (si01, si02) in the presence or absence of glutamate (16 h). Mitochondria are stained with MitoTracker Green. Scale bar: 10 μm, 63× magnification, n=3. (b, c) Representative measurement of mitochondrial ROS following glutamate exposure (16 h) in (b) HT22 CTR and cells transfected with scrambled siRNA (Scr) or siRNA against GRP75 (si01, si02), and (c) HT22 and GRP75 KO cells. Data are presented as mean + S.D., n=3, ***P<0.0001 compared with control, ###P<0.0001 compared with glutamate. CTR, control cells.